CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,321 shares at $20.88 ($69,342)
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 20,141 shares at an average $29.16 ($587,242)
- 4 Open-market sale EVP, Head of Research & Dev sold 16,558 shares at an average $26.13 ($432,663)
- 4 Planned sale PRINCIPAL ACCOUNTING OFFICER sold 11,421 shares at $26.08 ($297,912)
- 4 Grant or award Director acquired 37,244 shares (grant or award)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Option exercise Director acquired 2,010 shares (option exercise)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 5,401 shares at $21.18 ($114,393)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,332 shares at $21.79 ($29,024)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,506 shares at $21.79 ($76,396)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,709 shares at $22.20 ($60,140)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,030 shares at $22.20 ($22,866)
- 4 Open-market sale Chief Executive Officer sold 11,641 shares at $21.47 ($249,932)
- 4 Open-market sale EVP, Head of Research & Dev sold 3,435 shares at $21.47 ($73,749)
- 4 Open-market sale EVP, CHIEF LEGAL OFFICER, SEC sold 3,844 shares at $21.47 ($82,531)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,942 shares at an average $21.57 ($41,895)
Page 1 of 35 · 686 filings